Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ACORN-BP

Financiado

Development and Commercialisation of PVC DEHP Free Blood Packs To Ensure Approp...

Development and Commercialisation of PVC DEHP Free Blood Packs To Ensure Appropriate Control Of Red Cells Blood transfusion saves lives and improves health, but many patients requiring transfusion do not have timely access to safe blood. Currently, all commercially available blood bags are manufactured using Polyvinyl Chloride (PVC) a... ver más

31/10/2022

GLOBAL POLYMER CON...

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

GLOBAL POLYMER CONSULTING LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 5 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-10-31

EIC-FTI-2018-2020: Fast Track to Innovation (FTI)

I+D

Cerrada hace 6 años

0% 75% 100%

5 Participantes

GLOBAL POLYMER CONSULTING

538.03K€ | Lider

TECHNIGRAPHIC SYSTEMS SPAIN

360.50K€ | Participante

HAEMOTRONIC SPA

219.77K€ | Participante

NHSNSS - COMMON SERVICES AGE...

575.91K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 24 meses Fecha Inicio: 2020-10-16
Fecha Fin: 2022-10-31

Líder del proyecto

GLOBAL POLYMER CONSULTING LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Descripción del proyecto Blood transfusion saves lives and improves health, but many patients requiring transfusion do not have timely access to safe blood. Currently, all commercially available blood bags are manufactured using Polyvinyl Chloride (PVC) and a plasticizer called Di (2-ethylyhexyl) Phthalate (DEHP). DEHP is classified as a reproductive toxin and is listed in the Reach candidate list of Substances of Very High Concern (SVHC). DEHP-PVC bags are affecting our environment and our health adversely. 1. Through this 24 months FTI project Ducit Medical, Ireland along with our development partners Global Polymer Consulting, Ireland , Keifel Technologies Germany and Scottish National Blood Transfusion Service Scotland are developing a complete blood pack system ‘ACORN-BP’ which is PVC and DEHP free, thereby, reducing the threat posed by DEHP and which has no detrimental effect on the storage of red blood cells up to 42 days storage stability in-line with European Council guidelines. Once developed and accredited, ACORN-BP will be commercialised as a direct replacement of PVC-DEHP bags. Using the direct sales force model, we will target capturing 10.9% of the global PVC-DEHP blood pack market through a cumulative sales of <27million blood bags. This will generate cumulative revenues of >€216 million in the first five years, with a cumulative net profit of ~€65.60 million across the consortium. The ROI against total project costs of €3.53 million is ~18:1.

Conecta tu I+D

Entra hoy

¿Olvidó su contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores